EPHX2 and diabetes mellitus: sEH inhibition elevates EET levels, which would be expected to elicit a variety of beneficial biological effects [17] that effectively treat atherosclerosis, diabetes, hypertension, lung disease, pain, inflammation, immune disorders, and other diseases [18].